Stockreport

Opthea Reports Half-Year Financial Results and Business Updates

Opthea Limited - American Depositary Shares  (OPT) 
PDF Enrollment completion of sozinibercept Phase 3 program for wet AMD expected in calendar year (CY) Q2 2024 with top-line data mid-CY 2025 Expanded U.S. leadership tea [Read more]